Umbilical cord blood infusion to boost recovery in children with hard-to-treat solid tumors
Treatments studied
Part of Cancer clinical trials.
This study tests whether giving children their own or donor umbilical cord blood cells after chemotherapy can help their blood counts recover faster, allowing the next chemo round to start sooner. It's for children with solid tumors that have come back or not responded to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be between 1 and 18 years old
- Child has a solid tumor (like neuroblastoma or osteosarcoma) that is high-risk, has returned, or didn't respond to treatment
- Child needs more chemo, but their blood counts are very low and haven't recovered even after a week of standard care
- Child's major organs (liver, kidneys, heart) are working well enough
- Child is expected to live at least 12 weeks
- Family agrees to the study and to blood tests for immune monitoring
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
This trial tests whether infusing stem cells from umbilical cord blood can help your bone marrow recover and make healthy blood cells again after chemotherapy. The goal is to improve your blood counts and reduce the need for transfusions.
This trial studies transplanting healthy blood-forming cells from an umbilical cord blood donor who is not related to you. It may help people with certain blood cancers, immune disorders, or other serious diseases when a standard transplant plan is needed.
This trial tests a cord blood transplant after a reduced-intensity chemotherapy and radiation regimen for patients with high-risk blood cancers like leukemia, lymphoma, or MDS. The goal is to see if this approach can help destroy cancer cells and restore healthy blood cells.
This trial tests whether giving immune cells called NK cells from donated umbilical cord blood can help children and teens with high-risk or returning soft tissue sarcoma. The goal is to see if it is safe and effective when other treatments have been tried.
This trial tests a cord blood transplant using strong (myeloablative) chemotherapy to prepare your body, plus post-transplant treatment to reduce graft-versus-host disease (GVHD). It may help certain blood cancers when other transplant options are limited.
Hear when a new Pediatric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.